Treatment of infection of pneumoconiosis patients with inhalation of budesonide aerosol

Objective To observe the clinical effect of budesonide aerosol in the treatment of infection of pneumoconiosis patients.

Methods Totally 60 hospitalized pneumoconiosis patients with infection from January 2014 to January 2015 were studied. They were randomly divided into 2 groups, namely the routine treatment group (n=30) and the specific treatment group (n=30). Patients in the specific treatment group received inhalation of 2 mg budesonide aerosol twice a day for ten days, while the other treatment was the same as that in the control group, such as anti-inflammation, relieving asthma and oxygen therapy. The clinical therapeutic effects of these two groups of patients after treatment were compared.

Results On the 10th day after treatment, the curative effect of the specific treatment group was better than that of the routine treatment group (P < 0.05). The total effective rate was 96.7% in the specific treatment group and 73.3% in the routine treatment group. The patients'lung function in both groups was improved, but the FEV₁ and FEV₁/FVC of patients in the specific treatment group showed much better(P < 0.05).

Conclusion The clinical effect of budesonide aerosol in the treatment of complicated infection of pneumoconiosis patients was positive.